Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Carboxylic acids and derivatives >  Cyclic carboxylic acids >  1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID

Basic information Safety Supplier Related

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID Basic information

Product Name:
1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID
Synonyms:
  • 1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID
  • 4-b]pyridine-5-carboxylic acid
  • 1H-Pyrazolo[3,4-b]pyridine-5-carboxylicaci
CAS:
952182-02-4
MF:
C7H5N3O2
MW:
163.13
Mol File:
952182-02-4.mol
More
Less

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID Chemical Properties

Boiling point:
475.1±25.0 °C(Predicted)
Density 
1.617±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
10.24±0.40(Predicted)
Appearance
Light brown to off-white Solid
InChIKey
DRCBQOFOFJGWGA-UHFFFAOYSA-N
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36
Safety Statements 
26
HS Code 
2933399990
More
Less

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID Usage And Synthesis

Uses

1H-Pyrazolo[3,4-B]pyridine-5-carboxylic acid is an important pharmaceutical intermediate used in the synthesis of various drug compounds.

Synthesis

1086423-59-7

952182-02-4

Step 5. Ethyl 1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (4.4 g, 14 mmol) was dissolved in trifluoroacetic acid (TFA, 158 mL) and heated to 80 °C. The reaction mixture was stirred continuously at 80 °C for 4 hours. After completion of the reaction, the mixture was concentrated to dryness under reduced pressure. The residue was carefully poured into ice water and the pH was subsequently adjusted dropwise with 2 M aqueous sodium hydroxide (NaOH) to about 14. The precipitated solid was removed by filtration and the aqueous phase was washed with ethyl acetate. After combining the aqueous phases, the pH was adjusted to neutral (about 7) by slowly adding concentrated hydrochloric acid (HCl). The precipitate precipitated was collected by vacuum filtration and dried under vacuum to afford the target product 1H-pyrazolo[3,4-B]pyridine-5-carboxylic acid as a white solid (1 g, 80% yield). The product was characterized by 1H NMR (400 MHz, DMSO-d6): δ 14.38-13.62 (br, 1H), 9.07 (d, J = 1.6 Hz, 1H), 8.81 (d, J = 1.6 Hz, 1H), 8.32 (s, 1H). Mass spectrum (ESI+): m/z 164 [M+H]+.

References

[1] Patent: WO2013/127266, 2013, A1. Location in patent: Page/Page column 131; 133
[2] Patent: WO2013/127267, 2013, A1. Location in patent: Page/Page column 83; 84
[3] Patent: WO2013/127268, 2013, A1. Location in patent: Page/Page column 61; 62; 63
[4] Patent: WO2013/130935, 2013, A1. Location in patent: Paragraph 0182
[5] Patent: WO2013/130943, 2013, A1. Location in patent: Paragraph 0190

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACIDSupplier

Shangchem Co., Ltd.
Tel
+86-21-68182121
shanghai Rainbow MediTech.Co.Ltd.
Tel
021-64968085,64968086-5815,5812; 13472757003
Email
xiaoxia.zeng@rainbowpharma.cn
SpringPharma Tech Co.,Ltd
Tel
+86-25-68710855, +86-25-68710897
Email
sales@springpharma.net
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn
Wuhan ariel chemical Co., LTD.
Tel
18986259541
Email
sales@3stc.com